Stabilized Pharmaceutical
Patent 5541231 Issued on July 30, 1996. Estimated Expiration Date: 
August 25, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 25, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References Re33994 3819706 3885046 Compounds and methods of making same Compounds and methods of making them Compounds and methods of making Prolactin suppression in mammals 3H Labeled compounds Radioactive nuclide labeled propiophenone compounds Bupropion radioimmunoassay, and kit InventorsApplicationNo. 296252 filed on 08/25/1994US Classes:514/649, Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain514/769, DESIGNATED INORGANIC NONACTIVE INGREDIENT OR ELEMENTAL MATERIAL OTHER THAN WATER514/772DESIGNATED ORGANIC NONACTIVE INGREDIENT CONTAINING OTHER THAN HYDROCARBONExaminersPrimary: Rose, Shep K.Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/135Foreign Application Priority Data1993-07-30 GBAbstractThis application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80% of its initial bupropion potency after one year.Other References
| |
